Skip to content

Insertion Clinical Study to Evaluate the Aberration Characteristics of Kalifilcon A Toric Lenses

Insertion Clinical Study to Evaluate the Aberration Characteristics of Kalifilcon A Toric Lenses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05129072
Enrollment
75
Registered
2021-11-22
Start date
2021-08-25
Completion date
2021-09-24
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contact Lens Wearer

Brief summary

This objective of this clinical study aims to confirm whether multiple kalifilcon A daily disposable toric contact lenses are providing the intended level of spherical aberration correction when worn.

Interventions

DEVICEkalifilcon A Daily Disposable Toric LD213001 lens in SKUs +6D, +3D, 0D, -3D, -6D, and -9D

kalifilcon A Daily Disposable Toric LD213001 lens

Sponsors

Bausch & Lomb Incorporated
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Be 18 years or older on the date the Informed Consent Form (ICF) is signed and have capacity to read, understand and provide written voluntary informed consent. 2. Have physiologically normal anterior segments not exhibiting clinically significant biomicroscopy findings. 3. Have no active ocular disease or allergic conjunctivitis. 4. Not be using any topical ocular medications. 5. Be willing and able to follow instructions. 6. Have signed a statement of informed consent.

Exclusion criteria

1. Participating in a conflicting study in the opinion of the Investigator. 2. Considered by the Investigator to not be a suitable candidate for participation. 3. A women of childbearing potential (those who are not surgically sterilized or postmenopausal) are excluded from participation in the investigation if they meet any one of the following conditions: she is currently pregnant, she plans to become pregnant during the study, she is breastfeeding.

Design outcomes

Primary

MeasureTime frameDescription
Spherical Aberration Measurement60 minutesSpherical aberration (SA) occurs when light rays entering at different points of a spherical lens are not focused to the same point of the optical axis.

Secondary

MeasureTime frameDescription
Visibility of Toric Etch Mark by the Investigator60 minutesNumber of lenses the investigator could identify the toric etch mark

Countries

United States

Participant flow

Participants by arm

ArmCount
Kalifilcon A Daily Disposable Toric LD213001 Lens
kalifilcon A Daily Disposable Toric LD213001 lens in SKUs +6D, +3D, 0D, -3D, -6D, and -9D kalifilcon A Daily Disposable Toric LD213001 lens in SKUs +6D, +3D, 0D, -3D, -6D, and -9D: kalifilcon A Daily Disposable Toric LD213001 lens
75
Total75

Baseline characteristics

CharacteristicKalifilcon A Daily Disposable Toric LD213001 Lens
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
75 Participants
Age, Continuous49.2 Years
STANDARD_DEVIATION 11.27
Race and Ethnicity Not Collected— Participants
Region of Enrollment
United States
75 participants
Sex: Female, Male
Female
32 Participants
Sex: Female, Male
Male
43 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 75
other
Total, other adverse events
0 / 75
serious
Total, serious adverse events
0 / 75

Outcome results

Primary

Spherical Aberration Measurement

Spherical aberration (SA) occurs when light rays entering at different points of a spherical lens are not focused to the same point of the optical axis.

Time frame: 60 minutes

Population: 30 eyes wore the +3D, 0D, -3D, -6D, and -9D contact lenses. 26 eyes wore the +6D contact lenses.

ArmMeasureGroupValue (MEAN)Dispersion
Spherical Aberration of Kalifilcon A Daily Disposable Toric LD213001 LensSpherical Aberration MeasurementT04 (kali -3D)0.052 micronsStandard Deviation 0.145
Spherical Aberration of Kalifilcon A Daily Disposable Toric LD213001 LensSpherical Aberration MeasurementT05 (kali -6D)0.062 micronsStandard Deviation 0.158
Spherical Aberration of Kalifilcon A Daily Disposable Toric LD213001 LensSpherical Aberration MeasurementT01 (kali +6D)0.162 micronsStandard Deviation 0.187
Spherical Aberration of Kalifilcon A Daily Disposable Toric LD213001 LensSpherical Aberration MeasurementT02 (kali +3D)0.090 micronsStandard Deviation 0.12
Spherical Aberration of Kalifilcon A Daily Disposable Toric LD213001 LensSpherical Aberration MeasurementT03 (kali 0D)0.017 micronsStandard Deviation 0.133
Spherical Aberration of Kalifilcon A Daily Disposable Toric LD213001 LensSpherical Aberration MeasurementT06 (kali -9D)0.102 micronsStandard Deviation 0.164
Secondary

Visibility of Toric Etch Mark by the Investigator

Number of lenses the investigator could identify the toric etch mark

Time frame: 60 minutes

Population: 30 eyes wore the +3D, 0D, -3D, -6D, and -9D contact lenses. 26 eyes wore the +6D contact lenses.

ArmMeasureGroupValue (NUMBER)
Spherical Aberration of Kalifilcon A Daily Disposable Toric LD213001 LensVisibility of Toric Etch Mark by the InvestigatorT01 kali +6D26 Lenses
Spherical Aberration of Kalifilcon A Daily Disposable Toric LD213001 LensVisibility of Toric Etch Mark by the InvestigatorT02 kali +3D30 Lenses
Spherical Aberration of Kalifilcon A Daily Disposable Toric LD213001 LensVisibility of Toric Etch Mark by the InvestigatorT03 kali +0D30 Lenses
Spherical Aberration of Kalifilcon A Daily Disposable Toric LD213001 LensVisibility of Toric Etch Mark by the InvestigatorT04 kali -3D30 Lenses
Spherical Aberration of Kalifilcon A Daily Disposable Toric LD213001 LensVisibility of Toric Etch Mark by the InvestigatorT05 kali -6D30 Lenses
Spherical Aberration of Kalifilcon A Daily Disposable Toric LD213001 LensVisibility of Toric Etch Mark by the InvestigatorT06 kali -9D30 Lenses

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026